Neurofibromatosis 1 News and Research

RSS
Common pain and anti-inflammation drugs may slow cancer growth

Common pain and anti-inflammation drugs may slow cancer growth

Southern Society bestows 2016 Clinical Science Young Investigator Award to Stansfield

Southern Society bestows 2016 Clinical Science Young Investigator Award to Stansfield

Cancer causing genetic condition risk in children lower than previously thought

Cancer causing genetic condition risk in children lower than previously thought

UAB lab to offer new tests for genetic diseases using next-generation sequencing

UAB lab to offer new tests for genetic diseases using next-generation sequencing

Anticancer drug restores hearing in neurofibromatosis patients

Anticancer drug restores hearing in neurofibromatosis patients

UAB research explores neurofibromatosis type 1

UAB research explores neurofibromatosis type 1

Neurocutaneous disorders affect skin, nervous system

Neurocutaneous disorders affect skin, nervous system

New study reveals why some vestibular schwannomas cause hearing loss

New study reveals why some vestibular schwannomas cause hearing loss

MCG researchers explore how neurofibromatosis puts young patients at risk for cardiovascular disease

MCG researchers explore how neurofibromatosis puts young patients at risk for cardiovascular disease

FDA awards research grants to boost product development for patients with rare diseases

FDA awards research grants to boost product development for patients with rare diseases

Kolltan announces presentation of data from KTN0158 preclinical study in mast cell tumors at ESMO 2015

Kolltan announces presentation of data from KTN0158 preclinical study in mast cell tumors at ESMO 2015

UCSF researchers lead $10 million research project on pediatric cancer

UCSF researchers lead $10 million research project on pediatric cancer

Array Biopharma reports strong fourth quarter and full year 2015 financial results

Array Biopharma reports strong fourth quarter and full year 2015 financial results

Phase 3 SUMIT study: Selumetinib fails to meet primary endpoint in patients with metastatic uveal melanoma

Phase 3 SUMIT study: Selumetinib fails to meet primary endpoint in patients with metastatic uveal melanoma

Huntsman Cancer Institute receives NCI's Comprehensive Cancer Center designation

Huntsman Cancer Institute receives NCI's Comprehensive Cancer Center designation

Improved clinical management results in higher quality of life for patients with neurofibromatosis

Improved clinical management results in higher quality of life for patients with neurofibromatosis

Researchers map out surgical anatomy, approaches for auditory brainstem implant placement

Researchers map out surgical anatomy, approaches for auditory brainstem implant placement

Male genetic diversity declined due to wealth, power rather than `survival of fittest`

Male genetic diversity declined due to wealth, power rather than `survival of fittest`

Slow-growing tumors have treatment-resistant stem cells, shows study

Slow-growing tumors have treatment-resistant stem cells, shows study

UT Southwestern researchers identify possible therapy to treat neurofibromatosis type 1

UT Southwestern researchers identify possible therapy to treat neurofibromatosis type 1